Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT05523440
Title Bevacizumab and/or Niraparib in Patients With Recurrent Endometrial and/or Ovarian Cancer With ARID1A Mutation
Recruitment Recruiting
Gender female
Phase Phase II
Variant Requirements Yes
Sponsors University of Oklahoma
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Stephenson Cancer Center RECRUITING Oklahoma City Oklahoma 73104 United States Details
*Shaded cells indicate that there was no data available from for the field